跳至主要内容
临床试验/NCT05276856
NCT05276856招募中不适用

Rate of Recovery of Secondary Hypothyroidism in Patients With Pituitary Disorders.

Nova Scotia Health Authority1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2022年4月4日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
90
试验地点
1
主要终点
Percentage of patients achieving euthyroid status

研究概览

简要总结

The aim of this project is to assess the rate of recovery of secondary hypothyroidism in patients with pituitary disorders.

详细描述

The study will be conducted in three stages.

Stage 1 ( Patient identification and enrollment)

We will generate a list of all SHT patients from the HNP database and all patients will be contacted by the principal investigator (or their designate) regarding the study. Those patients who agree to participate in the study will be given a written consent form. We aim to enrol approximately 90 -100 patients for the study. Laboratory samples for serum TSH and T4 levels will be collected to confirm that all patients are adequately replaced for SHT. Those patients who are not adequately replaced and have low T4 will be excluded from the study.

Stage 2 (T4 withdrawal protocol)

Stepwise T4 replacement therapy will be initiated as follows.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed diagnosis of secondary hypothyroidism who are currently taking T4 replacement therapy

排除标准

  • uncontrolled cardiovascular disease
  • uncontrolled congestive heart failure
  • uncontrolled mental health disorder
  • not adequately replaced and have low T4 level.

结局指标

主要结局

Percentage of patients achieving euthyroid status

时间窗: 12 weeks

Percentage of patients able to maintain normal TSH/T4 without thyroxine replacment

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Recovery Rate in Secondary Hypothyroidism | 临床试验